Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes
International Journal of Laboratory Hematology · 2025
DOI: 10.1111/ijlh.14476 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Valentina Sangiorgio und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Mutation, Thrombosis, Thrombocytosis. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Italian Association for Cancer Research grant IG-22082 and IG-29341 (R.P.); Italian MUR Dipartimenti di Eccellenza 2023-2027 (l.…, the Italian Association for Cancer Research, Italian MUR Dipartimenti di Eccellenza 2023-2027.
Abstract (Originalsprache)
Introduction
The majority of patients with essential thrombocythemia (ET) show somatic mutations of JAK2, CALR , or MPL . Around 10% of cases lack these mutations (“triple negative” ET, TN‐ET). Additionally, some patients with bona fide “primary thrombocytosis” (PT) [i.e., high platelet (PLT)‐ count with no apparent underlying causes] do not fulfill the histologic criteria of ET. In this context, Next Generation Sequencing (NGS) can provide evidence of clonality and identify patients with different clinical behaviors.
Methods
We conducted a retro‐prospective analysis of 39 patients with TN‐PT and correlated the clinical and pathologic features with the molecular findings.
Results
Bone marrow histopathological features were consistent with ET in 60% of cases. After a mean follow up of 11.1 years, no cases of secondary myelofibrosis nor acute leukemia were observed. We reported 15 thrombotic events (TEs) in 10 (25.6%) patients. Considering mutations with a variant frequency ≥ 5%, 15.4% of patients showed at least one mutation (“NGS‐positive”); the remaining had no mutations (“NGS‐negative”). NGS status predicted the incidence of TEs: NGS‐positive patients experienced a significantly higher rate of TEs compared to NGS‐negative patients (66.6% vs. 18.2%, respectively; p = 0.01).
Conclusion
NGS status represents an adjunctive risk factor for thrombosis in TN‐PT and provides useful clinical information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
- Tettamanti Center, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
- Division of Hematology and Bone Marrow Unit, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
Förderung
- This work was supported by the Italian Association for Cancer Research grant IG-22082 and IG-29341 (R.P.); Italian MUR Dipartimenti di Eccellenza 2023-2027 (l.…
- the Italian Association for Cancer Research
- Italian MUR Dipartimenti di Eccellenza 2023-2027
- the European Union, Next Generation EU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 project PE_00000019 "HEAL ITALIA"
- European Joint Programme for Rare Diseases ERARE 2020
- Antonio Castelnuovo Foundation, Cermenate, Italy
Zitieren
APA
Sangiorgio, V., Mottadelli, F., Pagni, F., Cavalca, F., Cazzaniga, G., Venegoni, M., Gambacorti-Passerini, C., Piazza, R., & Maria Elli, E. (2025). Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14476
Vancouver
Sangiorgio V, Mottadelli F, Pagni F, Cavalca F, Cazzaniga G, Venegoni M, et al. Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14476
BibTeX
@article{Sangiorgio2025,
author = {Sangiorgio, Valentina and Mottadelli, Federica and Pagni, Fabio and Cavalca, Fabrizio and Cazzaniga, Giovanni and Venegoni, Martina and Gambacorti-Passerini, Carlo and Piazza, Rocco and Maria Elli, Elena},
title = {Next Generation Sequencing Identifies Subgroups of Patients With Triple Negative Primary Thrombocytosis With Different Clinical Thrombotic Outcomes},
journal = {International Journal of Laboratory Hematology},
year = {2025},
doi = {10.1111/ijlh.14476}
}
EUVIMED